NCT01635530View on ClinicalTrials.gov

Study of Lyme Neuroborreliosis

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Lyme Neuroborreliosis
Interventions
DRUG

Doxycycline

Doxycycline: 100mg tablet two times per day, four weeks

DRUG

Ceftriaxone

2 g intravenous once a day, three weeks

Trial Locations (2)

20521

Turku University Hospital, Turku

00029

Helsinki University Hospital, Helsinki

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT01635530 - Study of Lyme Neuroborreliosis | Biotech Hunter | Biotech Hunter